Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Northwestern University
Study ID
NCT00005095
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Ca-125 — OTHER
    Subject's blood collected at their follow-up blood draw will be assessed for biomarkers that could lead to a panel for detecting early stage ovarian cancer.
  • screening questionnaire administration — OTHER
    Questionnaires designed to assess quality of life for women at increased risk of ovarian cancer will be administered to the subjects. Clinical data will also be collected.
  • Surgery — PROCEDURE
    Subjects will be assessed for high risk factors.

Study Details

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Key Dates

Start date
Mar 31, 2000
Status verified
Feb 2025
Primary completion
Dec 31, 2030
Completion
Dec 31, 2040

Study Design

Enrollment
6,000 participants (estimated)

Arms

  • Arm: High Risk for Ovarian Cancer
    Women who are at increased risk of ovarian cancer based on family or personal medical history who are participating in the Northwestern Ovarian Cancer Early Detection and Prevention Program clinic.
  • Arm: Suspected or diagnosed gynecological condition
    Women who are planning to undergo surgery for their gynecological condition
  • Arm: Control Group
    Healthy subjects with no history of cancer and at general risk.

Primary Outcome Measure

The development of ultrasound and serum tumor markers for the detection and management of ovarian cancer and other [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Robert H. Lurie Comprehensive Cancer Center at Northwestern UniversityChicagoIllinois60611-3013
Clinical Trials Office - Robert H. Lurie Comprehensive Cancer
[email protected]
312-695-1301

Find similar trials in Chicago, IL

By condition
Cervical cancerEndometrial cancerOvarian cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Robert H. Lurie Comprehensive Cancer Center at Northwestern University· Chicago, IL

Related Studies